3-186618387-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001622.4(AHSG):c.574-149A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.446 in 1,309,236 control chromosomes in the GnomAD database, including 136,596 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as association (no stars).
Frequency
Genomes: 𝑓 0.36 ( 11868 hom., cov: 33)
Exomes 𝑓: 0.46 ( 124728 hom. )
Consequence
AHSG
NM_001622.4 intron
NM_001622.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.07
Genes affected
AHSG (HGNC:349): (alpha 2-HS glycoprotein) The protein encoded by this gene is a negatively-charged serum glycoprotein that is synthesized by hepatocytes. The encoded protein consists of two polypeptide chains, which are both cleaved from a proprotein encoded from a single mRNA. It is involved in several processes, including endocytosis, brain development, and the formation of bone tissue. Defects in this gene are a cause of susceptibility to leanness. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.597 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AHSG | NM_001622.4 | c.574-149A>G | intron_variant | ENST00000411641.7 | NP_001613.2 | |||
AHSG | NM_001354571.2 | c.577-149A>G | intron_variant | NP_001341500.1 | ||||
AHSG | NM_001354572.2 | c.571-149A>G | intron_variant | NP_001341501.1 | ||||
AHSG | NM_001354573.2 | c.574-149A>G | intron_variant | NP_001341502.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AHSG | ENST00000411641.7 | c.574-149A>G | intron_variant | 1 | NM_001622.4 | ENSP00000393887.2 |
Frequencies
GnomAD3 genomes AF: 0.358 AC: 54365AN: 152034Hom.: 11865 Cov.: 33
GnomAD3 genomes
AF:
AC:
54365
AN:
152034
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.458 AC: 529459AN: 1157084Hom.: 124728 AF XY: 0.461 AC XY: 260661AN XY: 565496
GnomAD4 exome
AF:
AC:
529459
AN:
1157084
Hom.:
AF XY:
AC XY:
260661
AN XY:
565496
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.357 AC: 54378AN: 152152Hom.: 11868 Cov.: 33 AF XY: 0.361 AC XY: 26858AN XY: 74380
GnomAD4 genome
AF:
AC:
54378
AN:
152152
Hom.:
Cov.:
33
AF XY:
AC XY:
26858
AN XY:
74380
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1771
AN:
3478
ClinVar
Significance: association
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Nephrolithiasis, calcium oxalate Other:1
association, no assertion criteria provided | case-control | Division of Molecular Genetics and Division of Molecular Medicine, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University | Mar 01, 2014 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at